<DOC>
	<DOC>NCT00063635</DOC>
	<brief_summary>The purpose of this study is to determine if therapeutic modification of insulin resistance or oxidative stress leads to improvement in serum or histologic indicators of liver injury or quality of life.</brief_summary>
	<brief_title>Treatment of Nonalcoholic Fatty Liver Disease in Children (TONIC)</brief_title>
	<detailed_description />
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin E</mesh_term>
	<mesh_term>Tocopherols</mesh_term>
	<mesh_term>Tocotrienols</mesh_term>
	<mesh_term>alpha-Tocopherol</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Age 817 years at first screening visit Histologic evidence of Nonalcoholic Fatty Liver Disease (NAFLD) biopsy cannot be older than 6 months as of randomization ALT level &gt;60 U/L at time of screening and on one previous occasion determined at least one month but no greater than 6 months prior to screening ALT Consent</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Non alcoholic fatty liver disease</keyword>
</DOC>